Growing Medical Acceptance of Psychedelics – The Daily Dive feat Derek Welsh of Revive Therapeutics

For our final episode of The Daily Dive this week, host Cassandra Leah is joined by that of Derek Welsh of Revive Therapeutics (CSE: RVV), and founder of Psilocin Pharma Corp, a subsidiary of the company. Derek joins us to discuss his outlook on that of the psychedelics market as a whole, and discuss what Revive is working on from a psychedelics standpoint.

Psilocin Pharma, which was acquired by Revive Therapeutics earlier this year, is the psychedelic-focused arm of the company. The company has developed production solutions for the active compound psilocybin. The firm has developed six formulations to date, while owning a robust pipeline of ongoing research and development work within the psychedelics space.


FULL DISCLOSURE: Revive Therapeutics is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Revive Therapeutics on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

Revive Closes Psilocin Pharma Acquisition, Releases Psilocybin Patent Details

Revive Therapeutics (CSE: RVV) has completed its previously announced acquisition of Psilocin Pharma Corp, a...

Thursday, March 5, 2020, 02:40:39 PM

Revive Therapeutics Conducts $10.0 Million Bought Deal Financing

Revive Therapeutics (CSE: RVV) this evening announced that it will be conducting a bought deal...

Wednesday, January 20, 2021, 08:37:25 PM

Yield Growth Corp Continues Push Towards Psychedelic Mushroom Investment Narrative

The Yield Growth Corp (CSE: BOSS) is continuing to push its recently announced psilocybin mushroom...

Tuesday, September 24, 2019, 10:35:14 AM

Revive Therapeutics Completes Psilocybin Oral Thin Film Strip Product

Revive Therapeutics (CSE: RVV) has completed its oral thin film strip product for psilocybin after...

Wednesday, November 11, 2020, 09:35:55 AM

Yield Growth Corp To Enter Mushroom and Psychoactive Space

The Yield Growth Corp (CSE: BOSS) is newly focused on the mushroom business – both...

Tuesday, September 17, 2019, 01:33:08 PM